← Back to All Filings

Sensus Healthcare (SRTS) Insider Corrects Ownership Filing

Low SignificanceDecember 16, 2025 at 3:03:12 PM EST

Sensus Healthcare, Inc.

$SRTS4/ACIK: 0001494891

Subscribe to track SRTS

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Sensus Healthcare (SRTS) Insider Corrects Ownership Filing

Company: Sensus Healthcare, Inc. (SRTS) Form: 4/A | Filed: 2025-12-16 Significance: Low

Insider: Sardano Michael Title: PRESIDENT AND GENERAL COUNSEL | Relationship: Director, Officer

Transaction: • Type: Correction of Holdings • Shares: N/A (No new transaction) • Price: N/A • Value: N/A • Owned After: 1,000 (Indirectly)

Key Insight: The insider filed this amendment to report 1,000 shares held by a spouse, which were inadvertently omitted from a previous Form 4. No new shares were bought or sold.

Market Context: This is an administrative correction of a minor holding and does not signal a change in the insider's view of the company. The holding is immaterial relative to the company's $70 million market cap.

View Full Filing

Comprehensive Analysis

SEC Filing Analysis: Sensus Healthcare, Inc. (SRTS)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: This Form 4/A is an administrative correction to report a small, indirect holding of 1,000 shares by the insider's spouse, which was previously omitted. No new transaction occurred.
  • Market Impact: Neutral. The filing is a non-event for the market as it does not represent new insider activity.

Company Information

FieldValue
CompanySensus Healthcare, Inc.
Ticker SymbolSRTS
CIK0001494891
IndustrySurgical & Medical Instruments & Apparatus

Insider Information

FieldValue
NameSardano Michael
CIK0001720602
Title/PositionPRESIDENT AND GENERAL COUNSEL
RelationshipDirector, Officer

Transaction Details

This filing is an amendment (Form 4/A) and does not report a new transaction. It corrects a prior report to include pre-existing holdings.

FieldValue
Form Type4/A
Period of Report2025-11-18
Transaction CodeNone
Security TypeCommon Stock
Shares Involved0
Price Per ShareN/A
Total Value$0
Shares Owned After1,000
Ownership TypeIndirect (spouse)

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$0
% of Market Cap0.0%
Shares Transacted0
% of Shares Outstanding0.0% (Shares Outstanding not available)
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: The company has a market capitalization of approximately $70 million. This filing corrects the record to show a holding of 1,000 shares, which is an immaterial amount relative to the company's size.
  • Transaction Significance: The filing has no transactional significance as it is purely administrative. It corrects an omission from a Form 4 filed on November 19, 2025.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The filing is a correction of a past record and does not involve any new purchase or sale of securities. It provides no new signal regarding the insider's sentiment or future company performance.

Volume & Sentiment

  • Expected Volume Impact: None. This is a non-event that is unlikely to influence trading activity.
  • Sentiment Indicator: Neutral. The filing is administrative in nature.

Additional Context

Transaction Notes

  • Special Circumstances: As noted in footnote F2, this filing's sole purpose is to correct a previous Form 4 that inadvertently omitted 1,000 shares held indirectly by the reporting person's spouse. The insider disclaims beneficial ownership of these shares.
Topics:#SECFiling#SensusHealthcare#SRTS#Form4A#InsiderTrading#StockMarket#FinancialReporting#CorporateGovernance

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.